STUDIES WITH LB 46, A NEW BETA-RECEPTOR BLOCKING DRUG

被引:49
作者
LUBAWSKI, I
WALE, J
机构
[1] Department of Pharmacology, University of Melbourne, Parkville
关键词
Specificity of action - LB 46; Specificity of action - propranolol; β-receptor antagonists;
D O I
10.1016/0014-2999(69)90195-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The specificity of the β-receptor antagonists propranolol and LB 46 [4-(2-hydroxy-3-isopropyl-aminopropoxy)-indole] has been compared by determination of their quinidine-like activities and antagonistic activity against isoprenaline, adrenaline, acetylcholine and histamine. LB 46 was 5 to 10 times more potent than propranolol as a β-receptor antagonist. It had stronger antimuscarinic activity, weaker antihistaminic activity and a slightly weaker quinidine-like activity than propranolol. © 1969.
引用
收藏
页码:345 / &
相关论文
共 3 条
[1]   SYNTHETIC SUBSTITUTES FOR QUINIDINE [J].
DAWES, GS .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1946, 1 (02) :90-112
[2]   PROPRANOLOL MJ 1999 AND CIBA 39089 BA IN OUABAIN AND ADRENALINE INDUCED CARDIAC ARRHYTHMIAS [J].
RAPER, C ;
WALE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 4 (01) :1-+
[3]   PA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM [J].
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1947, 2 (03) :189-206